Distinct Prognostic Value of Circulating Anti-Telomerase CD4+ Th1 Immunity and Exhausted PD-1+/TIM-3+ T Cells in Lung Cancer

British Journal of Cancer - United Kingdom
doi 10.1038/s41416-019-0531-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

84PPresence of Naturally Occurring Anti-Telomerase CD4 Th1 Immunity in Glioblastoma

Annals of Oncology
MedicineOncologyHematology
2017English

TIM-3 Is Expressed on Activated Human CD4+ T Cells and Regulates Th1 and Th17 Cytokines

European Journal of Immunology
AllergyImmunology
2009English

Reinvigorating Exhausted T Cells by Blockade of the PD-1 Pathway

Forum on Immunopathological Diseases and Therapeutics
BiochemistryBiotechnologyGeneticsMolecular Medicine
2015English

CD4+ T-Cell Immunity in the Peripheral Blood Correlates With Response to Anti-Pd-1 Therapy

Cancer immunology research
Cancer ResearchImmunology
2019English

Dopamine Receptor D3 Signaling on CD4+T Cells Favors Th1- And Th17-Mediated Immunity

Journal of Immunology
AllergyImmunology
2016English

Tim-3 and Its Role in Regulating Anti-Tumor Immunity

Immunological Reviews
AllergyImmunology
2017English

Enhancement of Anti-Telomerase Immunity Against Prostate Cancer

2005English

PD-1 and Tim-3 Regulate the Expansion of Tumor Antigen-Specific CD8+ T Cells Induced by Melanoma Vaccines

Cancer Research
Cancer ResearchOncology
2013English

Revealing the Role of CD4+T Cells in Viral Immunity: Figure 1.

Journal of Experimental Medicine
MedicineAllergyImmunology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy